Oxindole derivatives

Details for Australian Patent Application No. 2006260934 (hide)

Owner F. Hoffmann-La Roche AG

Inventors So, Sung-Sau; Zhang, Zhuming; Zhang, Jing; Luk, Kin-Chun

Agent Davies Collison Cave

Pub. Number AU-B-2006260934

PCT Pub. Number WO2006/136606

Priority 60/693,752 24.06.05 US; 60/795,616 27.04.06 US

Filing date 22 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 29 March 2012

International Classifications

C07D 209/34 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/136606 Priority application(s): WO2006/136606

29 March 2012 Application Accepted

  Published as AU-B-2006260934

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006260947-Process for obtaining lipid from cells

2006260933-Method and system for filtering electronic messages